Agents which upregulate ACE2, such as Diminazene [72,73,74] and angiotensin II inhibitors, reduce the RAS toxic angiotensin II implicated in the storm of cytokines and in pneumonia, one of the symptoms of COVID-19. The gene discussed is AGT; the disease is susceptibility to pneumonia measurement.